HYDERABAD, INDIA & REYKJAVIK, ICELAND (May 22, 2024) — Alvotech , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide (“Alvotech”), and Dr.
Continue ReadingAlvotech, Dr. Reddy’s Partner to Commercialize AVT03 Biosimilar in US, Europe, UK
Hyderabad India; April 11, 2024 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; hereafter referred to as “Dr. Reddy’s”), a global pharmaceutical company, announced the
India; October 26, 2023 – Dr. Reddy’s Laboratories Ltd., a global pharmaceutical company, today announced the launch of its first direct-to-consumer (D2C) e-commerce website ‘Celevida Wellness’ for diabetes patients by